SOS1-IN-7

发表于2024年11月22日由上海金畔生物科技有限公司

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

SOS1-IN-7

SOS1-IN-7 (compound 18-p1) 是一种有效的 SOS1 抑制剂，对 SOS1-G12D 和SOS1-G12V 的 IC₅₀ 分别为 20 和 67 nM。

SOS1-IN-7 Chemical Structure

CAS No. : 2755415-30-4

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

SOS1-IN-7 (compound 18-p1) is a potent SOS1 inhibitor with IC₅₀s of 20 and 67 nM for SOS1-G12D and SOS1-G12V, respectively^[1].

IC₅₀ & Target^[1]

SOS1-G12D

20 nM (IC₅₀)

SOS1-G12V

67 nM (IC₅₀)

分子量

462.46

Formula

C₂₃H₂₅F₃N₄O₃

CAS 号

2755415-30-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Pyridine-pyrimidine derivative, preparation method therefor and pharmaceutical use thereof. WO2021249519A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

SOS1-IN-6

发表于2024年11月22日由上海金畔生物科技有限公司

SOS1-IN-6

SOS1-IN-6 (compound 33-P1) 是一种有效的 SOS1 抑制剂，对 SOS1-G12D 和 SOS1-G12V 的 IC₅₀ 分别为 14.9 和 73.3 nM。

SOS1-IN-6 Chemical Structure

CAS No. : 2751718-88-2

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

SOS1-IN-6 (compound 33-P1) is a potent SOS1 inhibitor with IC₅₀s of 14.9 and 73.3 nM for SOS1-G12D and SOS1-G12V, respectively^[1].

IC₅₀ & Target^[1]

SOS1-G12D

14.9 nM (IC₅₀)

SOS1-G12V

73.3 nM (IC₅₀)

分子量

471.51

Formula

C₂₆H₂₈F₃N₃O₂

CAS 号

2751718-88-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Fused quinazoline derivative, preparation method therefor and application thereof in medicine. WO2021249475A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

SOS1-IN-7

发表于2024年11月22日由上海金畔生物科技有限公司

SOS1-IN-7

SOS1-IN-7 (compound 18-p1) 是一种有效的 SOS1 抑制剂，对 SOS1-G12D 和SOS1-G12V 的 IC₅₀ 分别为 20 和 67 nM。

SOS1-IN-7 Chemical Structure

CAS No. : 2755415-30-4

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

SOS1-IN-7 (compound 18-p1) is a potent SOS1 inhibitor with IC₅₀s of 20 and 67 nM for SOS1-G12D and SOS1-G12V, respectively^[1].

IC₅₀ & Target^[1]

SOS1-G12D

20 nM (IC₅₀)

SOS1-G12V

67 nM (IC₅₀)

分子量

462.46

Formula

C₂₃H₂₅F₃N₄O₃

CAS 号

2755415-30-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Pyridine-pyrimidine derivative, preparation method therefor and pharmaceutical use thereof. WO2021249519A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

SOS1 activator 1

发表于2024年11月19日由上海金畔生物科技有限公司

SOS1 activator 1

SOS1 activator 1 (Compound 64) 是 SOS1 介导的核苷酸交换的激活剂，K_d 为 44 nM。SOS1 是一种鸟嘌呤核苷酸交换因子，能与 Ras 蛋白结合，并使原来与 Ras 结合的 GDP 交换成GTP。可催化 GDP 与 RAS 上的 GTP 交换。

SOS1 activator 1 Chemical Structure

CAS No. : 2245237-53-8

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性	SOS1 activator 1 (Compound 64) is a potent activator of SOS1-mediated nucleotide exchange with a K_d of 44 nM. SOS1 is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS^[1].
分子量	483.02
Formula	C₂₆H₃₂ClFN₆
CAS 号	2245237-53-8
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Timothy R Hodges, et al. Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS. J Med Chem. 2018 Oct 11;61(19):8875-8894.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

SOS1 activator 1

发表于2024年11月19日由上海金畔生物科技有限公司

SOS1 activator 1

SOS1 activator 1 Chemical Structure

CAS No. : 2245237-53-8

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性	SOS1 activator 1 (Compound 64) is a potent activator of SOS1-mediated nucleotide exchange with a K_d of 44 nM. SOS1 is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS^[1].
分子量	483.02
Formula	C₂₆H₃₂ClFN₆
CAS 号	2245237-53-8
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Timothy R Hodges, et al. Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS. J Med Chem. 2018 Oct 11;61(19):8875-8894.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

SOS1 activator 1

发表于2024年11月18日由上海金畔生物科技有限公司

SOS1 activator 1

SOS1 activator 1 Chemical Structure

CAS No. : 2245237-53-8

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性	SOS1 activator 1 (Compound 64) is a potent activator of SOS1-mediated nucleotide exchange with a K_d of 44 nM. SOS1 is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS^[1].
分子量	483.02
Formula	C₂₆H₃₂ClFN₆
CAS 号	2245237-53-8
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Timothy R Hodges, et al. Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS. J Med Chem. 2018 Oct 11;61(19):8875-8894.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

PROTAC SOS1 degrader-2

发表于2024年11月15日由上海金畔生物科技有限公司

PROTAC SOS1 degrader-2

PROTAC SOS1 degrader-2 是一种有效的 PROTAC SOS1 降解剂。 PROTAC SOS1 Degrader-2 以剂量依赖性方式降低 pERK 和 RAS-GTP 的表达水平。PROTAC SOS1degrader-2 在体内显著抑制肿瘤生长。

PROTAC SOS1 degrader-2 Chemical Structure

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

PROTAC SOS1 degrader-2 is a potent PROTAC SOS1 degrader. PROTAC SOS1 degrader-2 decreases the expression of pERK and RAS-GTP level in a dose-dependent manner. PROTAC SOS1 degrader-2 significantly inhibits the tumor growth in vivo^[1].

IC₅₀ & Target^[1]

K-RAS

体外研究
(In Vitro)

PROTAC SOS1 degrader-2 (compound 9d) (0.1, 1 µM) shows a potent SOSI degradation activity with an SOS1 protein degradation of 56.2 and 92.5% at 0.1 and 1 μM in NCI-H358 cells, respectively^[1].
PROTAC SOS1 degrader-2 (24 h) degrades SOS1 in a dose- and time-dependent manner in NCI-H358 cells^[1].
PROTAC SOS1 degrader-2 (9.8-2500 nM; 24 h) does not induce SOS2 and KRAS degradation in NCI-H358 cells^[1].
PROTAC SOS1 degrader-2 (7.8-2000 nM; 24 h) decreases the expression of pERK and RAS-GTP level in NCI-H358 cells in a dose-dependent manner^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:	NCI-H358 cells
Concentration:	7.8, 15.6, 31.2, 62.5, 125, 250, 500, 1000, 2000 nM
Incubation Time:	24 h
Result:	Showed a potent degradation activity with an EC₅₀ of 98.4 nM in NCI-H358 cells.

RT-PCR^[1]

Cell Line:	NCI-H358 cells
Concentration:	1 µM
Incubation Time:	24, 48, 72 h
Result:	Showed the SOS2 mRNA level remained constant during the incubation period.

Cell Proliferation Assay^[1]

Cell Line:	NCI-H358, MIA PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells
Concentration:	0-10000 nM
Incubation Time:	7 days
Result:	Inhibited the cell growth with IC₅₀s of 0.525, 0.218, 0.307, 0.115, 0.199, 0.232 µM (EC₅₀s of 0.098, 0.255, 0.119, 0.104, 0.125, 0.022 µM)for NCI-H358, MIA PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells, respectively.

体内研究
(In Vivo)

PROTAC SOS1 degrader-2 (10, 20 mg/kg; i.p., daily for 21 days ) significantly inhibits the tumor growth in vivo with a good safety profile^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	BALB/c nude mice (NCI-H358 tumor xenografts)^[1]
Dosage:	10, 20 mg/kg
Administration:	I.p.; daily, 21 days
Result:	Significantly inhibited the tumor growth in vivo with a good safety profile.

分子量

1051.79

Formula

C₅₇H₇₆ClFN₁₀O₄S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Zhou C,et al. Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. J Med Chem. 2022; 65(5):3923-3942.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

PROTAC SOS1 degrader-2

发表于2024年11月15日由上海金畔生物科技有限公司

PROTAC SOS1 degrader-2

PROTAC SOS1 degrader-2 Chemical Structure

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

IC₅₀ & Target^[1]

K-RAS

体外研究
(In Vitro)

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:	NCI-H358 cells
Concentration:	7.8, 15.6, 31.2, 62.5, 125, 250, 500, 1000, 2000 nM
Incubation Time:	24 h
Result:	Showed a potent degradation activity with an EC₅₀ of 98.4 nM in NCI-H358 cells.

RT-PCR^[1]

Cell Line:	NCI-H358 cells
Concentration:	1 µM
Incubation Time:	24, 48, 72 h
Result:	Showed the SOS2 mRNA level remained constant during the incubation period.

Cell Proliferation Assay^[1]

Cell Line:	NCI-H358, MIA PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells
Concentration:	0-10000 nM
Incubation Time:	7 days
Result:	Inhibited the cell growth with IC₅₀s of 0.525, 0.218, 0.307, 0.115, 0.199, 0.232 µM (EC₅₀s of 0.098, 0.255, 0.119, 0.104, 0.125, 0.022 µM)for NCI-H358, MIA PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells, respectively.

体内研究
(In Vivo)

PROTAC SOS1 degrader-2 (10, 20 mg/kg; i.p., daily for 21 days ) significantly inhibits the tumor growth in vivo with a good safety profile^[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	BALB/c nude mice (NCI-H358 tumor xenografts)^[1]
Dosage:	10, 20 mg/kg
Administration:	I.p.; daily, 21 days
Result:	Significantly inhibited the tumor growth in vivo with a good safety profile.

分子量

1051.79

Formula

C₅₇H₇₆ClFN₁₀O₄S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Zhou C,et al. Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. J Med Chem. 2022; 65(5):3923-3942.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

PROTAC SOS1 degrader-2

发表于2024年11月15日由上海金畔生物科技有限公司

PROTAC SOS1 degrader-2

PROTAC SOS1 degrader-2 Chemical Structure

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

IC₅₀ & Target^[1]

K-RAS

体外研究
(In Vitro)

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:	NCI-H358 cells
Concentration:	7.8, 15.6, 31.2, 62.5, 125, 250, 500, 1000, 2000 nM
Incubation Time:	24 h
Result:	Showed a potent degradation activity with an EC₅₀ of 98.4 nM in NCI-H358 cells.

RT-PCR^[1]

Cell Line:	NCI-H358 cells
Concentration:	1 µM
Incubation Time:	24, 48, 72 h
Result:	Showed the SOS2 mRNA level remained constant during the incubation period.

Cell Proliferation Assay^[1]

Cell Line:	NCI-H358, MIA PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells
Concentration:	0-10000 nM
Incubation Time:	7 days
Result:	Inhibited the cell growth with IC₅₀s of 0.525, 0.218, 0.307, 0.115, 0.199, 0.232 µM (EC₅₀s of 0.098, 0.255, 0.119, 0.104, 0.125, 0.022 µM)for NCI-H358, MIA PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells, respectively.

体内研究
(In Vivo)

PROTAC SOS1 degrader-2 (10, 20 mg/kg; i.p., daily for 21 days ) significantly inhibits the tumor growth in vivo with a good safety profile^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	BALB/c nude mice (NCI-H358 tumor xenografts)^[1]
Dosage:	10, 20 mg/kg
Administration:	I.p.; daily, 21 days
Result:	Significantly inhibited the tumor growth in vivo with a good safety profile.

分子量

1051.79

Formula

C₅₇H₇₆ClFN₁₀O₄S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Zhou C,et al. Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. J Med Chem. 2022; 65(5):3923-3942.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

PROTAC SOS1 degrader-1

发表于2024年11月8日由上海金畔生物科技有限公司

PROTAC SOS1 degrader-1

PROTAC SOS1degrader-1 是一种有效的 PROTAC SOS1 激动剂，DC₅₀ 为 98.4 nM。PROTAC SOS1 Degrader-1 在各种 KRAS 突变的癌细胞中显示出抗增殖活性。PROTAC SOS1 Degrader-1 具有抗肿瘤作用，且具有低毒性。

PROTAC SOS1 degrader-1 Chemical Structure

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

PROTAC SOS1 degrader-1 is a potent PROTAC SOS1 agonist with an DC₅₀ of 98.4 nM. PROTAC SOS1 degrader-1 shows antiproliferation activity in cancer cells with various KRAS mutations. PROTAC SOS1 degrader-1 shows antitumor effect with low toxicity^[1].

IC₅₀ & Target

DC₅₀: 98.4 nM (SOS1)^[1]

体外研究
(In Vitro)

PROTAC SOS1 degrader-1 (compound 9d) (0.1, 1 µM) shows SOSI degradation activity with an SOS1 protein degradation of 56.2 and 92.5% at 0.1 and 1 μM, respectively^[1].
PROTAC SOS1 degrader-1 (0-2000 nM; 24 h) exhibits SOS1 degradation activity with an DC₅₀ of 98.4 nM in a dose- and time-dependent manner in NCI-H358 cells^[1].
PROTAC SOS1 degrader-1 (0-2500 nM; 24 h) dose-dependently reduced the SOS1 protein level but showed no effect on SOS2 and KRAS up to 2.5 μM in NCI-H358 and AsPc-1 cells^[1].
PROTAC SOS1 degrader-1 (0-2000 nM; 24 h) reduces the expression of KRAS-GTP, induced ERK phosphorylation with an IC₅₀value of 72.3 nM, and significantly increases the pERK level after 6-24 h^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:	NCI-H358 cells
Concentration:	0-2000 nM
Incubation Time:	0-24 h
Result:	Decreased the expression of SOS1 in a dose- and time-dependent manner in NCI-H358 cells.

RT-PCR^[1]

Cell Line:	NCI-H358 cells
Concentration:	1 µM
Incubation Time:	24, 48, 72 h
Result:	Showed no effffect on SOS2 mRNA expression.

Cell Proliferation Assay^[1]

Cell Line:	NCI-H358, MIA-PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells
Concentration:	0-10000 nM
Incubation Time:	7 days
Result:	Showed anti-proliferation activity with an IC₅₀s of 0.525, 0.218, 0.307, 0.115, 0.199, 0.232 µM and DC₅₀s of 0.098, 0.255, 0.119, 0.104, 0.125, 0.022 µM for NCI-H358, MIA-PaCa2, AsPC-1, SK-LU-1, SW620, A549 cells, respectively.

体内研究
(In Vivo)

PROTAC SOS1 degrader-1 (10 mg/kg; i.p.) shows good PK profile with low toxicity^[1].
PROTAC SOS1 degrader-1 (0, 10, 20 mg/kg; i.p.; once a day for 3 weeks) shows significant anti-tumor activities in the xenograft mouse model^[1].
Pharmacokinetic Parameters of PROTAC SOS1 degrader-1 in BALB/c mice^[1].

compound	dose (mg/kg)	T_1/2 (h)	T_max (h)	C_max (ng/mL)	AUC_last (h*ng/mL)	AUC_INF (h*ng/mL)	MRT_INF-obs(h)
9d	10	8.64±0.31	0.250v±0	1221±132	3895±335	4420±363	10.2±0.4

Male BALB/c mice; 10 mg/kg for i.p.^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male BALB/c mice^[1]
Dosage:	10 mg/kg (dissolved in solution containing dimethyl sulfoxide, PEG400, and 10% hydroxypropyl-β-cyclodextrin in water (5/5/90, v/v/v))
Administration:	I.p.
Result:	Showed good PK profile with high exposure (AUC_0‑∞ = 4420 h*ng/mL) and maximum concentration (C_max = 1221 ng/mL) in mouse plasma.

Animal Model:	6-8 weeks, BALB/c mice ^[1]
Dosage:	0, 10, 20 mg/kg
Administration:	I.p.; once a day for a week
Result:	Showed low toxicity for mouse.

Animal Model:	6-8 weeks, BALB/c nude mice (NCI-H358 tumor xenografts) ^[1]
Dosage:	0, 10, 20 mg/kg
Administration:	I.p.; once a day for 3 weeks;
Result:	Inhibited the tumor growth by 72.5 and 86.1% at 10 and 20 mg/kg, respectively.

Animal Model:	6-8 weeks, BALB/c nude mice (NCI-H358 tumor xenografts)^[1]
Dosage:	0, 20, 50 mg/kg
Administration:	Intratumoral injection; twice-weekly for 5 weeks
Result:	Significantly prevented tumor growth in vivo with a good safety profile.

分子量

1051.79

Formula

C₅₇H₇₆ClFN₁₀O₄S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Zhou C, et al. Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. J Med Chem. 2022 Mar 10;65(5):3923-3942.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

BAY-293

发表于2024年10月7日由上海金畔生物科技有限公司

BAY-293 纯度: 98.06%

BAY-293 是一种有价值的化学探针，通过破坏 KRAS-SOS1 相互作用从而阻断 RAS 活化，IC₅₀ 为 21 nM。BAY-293 是一种有效的 SOS1 抑制剂。SOS1 是一种鸟苷酸交换因子 (GEF)，也是 RAS 的激活剂。

BAY-293 Chemical Structure

CAS No. : 2244904-70-7

规格	价格	是否有货
Free Sample (0.1-0.5 mg)		Apply now
10 mM * 1 mL in DMSO	￥2530	In-stock
5 mg	￥2300	In-stock
10 mg	￥4150	In-stock
50 mg		询价
100 mg		询价

* Please select Quantity before adding items.

BAY-293 相关产品

•相关化合物库:

Bioactive Compound Library Plus
GPCR/G Protein Compound Library
Kinase Inhibitor Library
Anti-Cancer Compound Library
Ferroptosis Compound Library
Chemical Probe Library
Glutamine Metabolism Compound Library
Anti-Lung Cancer Compound Library
Anti-Pancreatic Cancer Compound Library
Anti-Blood Cancer Compound Library
Angiogenesis Related Compound Library
Anti-Liver Cancer Compound Library
Anti-Colorectal Cancer Compound Library

生物活性

BAY-293, a valuable chemical probe, blocks RAS activation via disruption of the KRAS-SOS1 interaction with an IC₅₀ of 21 nM. BAY-293 is a potent inhibitor of Son of Sevenless 1 (SOS1). SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS^[1].

IC₅₀ & Target^[1]

KRAS-SOS1

21 nM (IC₅₀)

体外研究
(In Vitro)

BAY-293 inhibits the activation of RAS in HeLa cells, with IC₅₀ values in the submicromolar range^[1].
BAY-293 (595 nM-3580 nM; 72 hours) shows efficient antiproliferative activity against wild-type KRAS cell lines (K-562, MOLM-13) and cell lines with KRAS^G12C mutation (NCI-H358, Calu-1)^[1].
BAY-293 efficiently inhibits pERK levels in K-562 cells after incubation for 60 min without affecting total protein levels of ERK^[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:	K-562, MOLM-13, H358 and Calu-1 cell lines
Concentration:	595-3580 nM
Incubation Time:	72 hours
Result:	IC₅₀s of 1,090±170 nM, 995±400 nM, 3,480±100 nM and 3,190±50 nM for K-562, MOLM-13, H358 and Calu-1 cells, respectively.

分子量

448.58

Formula

C₂₅H₂₈N₄O₂S

CAS 号

2244904-70-7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

DMSO : ≥ 125 mg/mL (278.66 mM)

* “≥” means soluble, but saturation unknown.

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.2293 mL	11.1463 mL	22.2926 mL
5 mM	0.4459 mL	2.2293 mL	4.4585 mL
10 mM	0.2229 mL	1.1146 mL	2.2293 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline

Solubility: ≥ 2.08 mg/mL (4.64 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (4.64 mM，饱和度未知) 的澄清溶液。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% corn oil

Solubility: ≥ 2.08 mg/mL (4.64 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (4.64 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在上海金畔生物科技有限公司网站选购。

参考文献

[1]. Hillig RC, et al. Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1interaction. Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2551-2560.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

SOS1-IN-8

发表于2024年4月29日由上海金畔生物科技有限公司

SOS1-IN-8

SOS1-IN-8 是一种有效的 SOS1 抑制剂，对 SOS1-G12D 和 SOS1-G12V 的IC₅₀ 分别为 11.6 和 40.7 nM。

SOS1-IN-8 Chemical Structure

CAS No. : 2759387-92-1

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性

SOS1-IN-8 is a potent SOS1 inhibitor with IC₅₀s of 11.6 and 40.7 nM for SOS1-G12D and SOS1-G12V, respectively (WO2022017339A1, compound 2)^[1].

IC₅₀ & Target^[1]

SOS1-G12D

11.6 nM (IC₅₀)

SOS1-G12V

40.7 nM (IC₅₀)

分子量

477.48

Formula

C₂₄H₂₆F₃N₃O₄

CAS 号

2759387-92-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Fused pyridazine derivative, preparation method therefor and pharmaceutical use thereof. WO2022017339A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

SOS1-IN-11

发表于2024年4月14日由上海金畔生物科技有限公司

SOS1-IN-11

SOS1-IN-11 是一种有效的 SOS1 抑制剂，其 IC₅₀ 值为 30 nM。

SOS1-IN-11 Chemical Structure

CAS No. : 2654741-64-5

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性	SOS1-IN-11 is a potent SOS1 inhibitor with an IC₅₀ value of 30 nM.
分子量	431.45
Formula	C₂₂H₂₄F₃N₅O
CAS 号	2654741-64-5
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Matthew Arnold Marx, et al. Sos1 inhibitors. WO2021127429 A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

MRTX0902

发表于2024年3月5日由上海金畔生物科技有限公司

MRTX0902

MRTX0902 是一种有效的 SOS1 的抑制剂，IC₅₀ 为 46 nM。

MRTX0902 Chemical Structure

CAS No. : 2654743-22-1

规格	价格	是否有货
5 mg	￥9500	询问价格 & 货期
10 mg	￥15000	询问价格 & 货期

* Please select Quantity before adding items.

生物活性

MRTX0902 is a potent SOS1 inhibitor with an IC₅₀ of 46 nM (WO2021127429A1; Example 12-10)^[1].

IC₅₀ & Target^[1]

KRAS-SOS1

46 nM (IC₅₀)

分子量

388.47

Formula

C₂₂H₂₄N₆O

CAS 号

2654743-22-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Matthew Arnold Marx, et al. Sos1 inhibitors. WO2021127429A1.

[2]. Matthew Arnold Marx, et al. Sos1 inhibitors. WO2021127429A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

NSC-658497

发表于2023年12月25日由上海金畔生物科技有限公司

NSC-658497

NSC-658497 是一种有效的 SOS1 抑制剂。NSC-658497 与 SOS1 结合，竞争性抑制 SOS1-Ras 相互作用，并呈剂量依赖性抑制 SOS1-GEF 活性。NSC-658497 在抑制 Ras、下游信号活动和相关细胞增殖方面显示出剂量依赖性功效。

NSC-658497 Chemical Structure

CAS No. : 909197-38-2

规格		是否有货
5 mg		询价
10 mg		询价

* Please select Quantity before adding items.

生物活性

NSC-658497 is an effective inhibitor of Ras-GEF, SOS1. NSC-658497 binds to SOS1, competitively suppresses SOS1-Ras interaction, and dose-dependently inhibits SOS1 GEF activity. NSC-658497 showed dose-dependent efficacy in inhibiting Ras, downstream signaling activities, and associated cell proliferation^[1].

体外研究
(In Vitro)

NSC-658497 (0-20 μM; 2 hours; NIH/3T3 cells) dose-dependently inhibits EGF (50 ng/mL)-stimulated Ras, but not EGFR activation^[1].
Concomitant to Ras inhibition, NSC-658497 (0-100 μM; 2 hours; NIH/3T3 cells) dose-dependently inhibited the EGF activated, Ras downstream targets ERK1/2 and AKT^[1].
Consistent with these results, NSC-658497 dose-dependently suppressed Ras signaling mediated by the overexpression of an active SOS1 mutant (W729L), originally identified in Noonan’s Syndrome, in human embryonic kidney cells^[1].
NSC-658497 dose-dependently inhibits 50 nM SOS1-cat mediated GDP/GTP nucleotide exchange upon 2 μM H-Ras (aa. 1-166) in the BODIPYFL-GDP dissociation assay (IC₅₀=15.4μM)^[1].
NSC-658497 (0-60 μM; 3 days; PC-3 and DU-145 cells) inhibits proliferation of prostate cancer cells^[1].
NSC-658497 (0-60 μM; 2 hours; PC-3 and DU-145 cells) dose-dependently inhibits Ras-GTP activity and the downstream p-ERK1/2 and p-Akt activities^[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:	PC-3 and DU-145 cells
Concentration:	0-60 μM
Incubation Time:	3 days
Result:	Dose-dependently inhibited proliferation of PC-3 and DU-145 cells.

Western Blot Analysis^[1]

Cell Line:	PC-3 and DU-145 cells
Concentration:	0-60 μM
Incubation Time:	2 hours
Result:	Dose-dependently inhibited Ras-GTP activity and the downstream p-ERK1/2 and p-Akt activities.

分子量

438.43

Formula

C₂₀H₁₀N₂O₆S₂

CAS 号

909197-38-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Evelyn CR, et al. Rational design of small molecule inhibitors targeting the Ras GEF, SOS1. Chem Biol. 2014;21(12):1618-1628.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

NSC-658497

发表于2023年12月24日由上海金畔生物科技有限公司

NSC-658497

NSC-658497 Chemical Structure

CAS No. : 909197-38-2

规格		是否有货
5 mg		询价
10 mg		询价

* Please select Quantity before adding items.

生物活性

体外研究
(In Vitro)

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:	PC-3 and DU-145 cells
Concentration:	0-60 μM
Incubation Time:	3 days
Result:	Dose-dependently inhibited proliferation of PC-3 and DU-145 cells.

Western Blot Analysis^[1]

Cell Line:	PC-3 and DU-145 cells
Concentration:	0-60 μM
Incubation Time:	2 hours
Result:	Dose-dependently inhibited Ras-GTP activity and the downstream p-ERK1/2 and p-Akt activities.

分子量

438.43

Formula

C₂₀H₁₀N₂O₆S₂

CAS 号

909197-38-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Evelyn CR, et al. Rational design of small molecule inhibitors targeting the Ras GEF, SOS1. Chem Biol. 2014;21(12):1618-1628.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

NSC-658497

发表于2023年12月24日由上海金畔生物科技有限公司

NSC-658497

NSC-658497 Chemical Structure

CAS No. : 909197-38-2

规格		是否有货
5 mg		询价
10 mg		询价

* Please select Quantity before adding items.

生物活性

体外研究
(In Vitro)

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:	PC-3 and DU-145 cells
Concentration:	0-60 μM
Incubation Time:	3 days
Result:	Dose-dependently inhibited proliferation of PC-3 and DU-145 cells.

Western Blot Analysis^[1]

Cell Line:	PC-3 and DU-145 cells
Concentration:	0-60 μM
Incubation Time:	2 hours
Result:	Dose-dependently inhibited Ras-GTP activity and the downstream p-ERK1/2 and p-Akt activities.

分子量

438.43

Formula

C₂₀H₁₀N₂O₆S₂

CAS 号

909197-38-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献

[1]. Evelyn CR, et al. Rational design of small molecule inhibitors targeting the Ras GEF, SOS1. Chem Biol. 2014;21(12):1618-1628.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

whatman (沃特曼)

英国沃特曼 Millipore PALL中国代理商金畔官网

标签归档：sos

SOS1-IN-7

SOS1-IN-6

SOS1-IN-7

SOS1 activator 1

SOS1 activator 1

SOS1 activator 1

PROTAC SOS1 degrader-2

PROTAC SOS1 degrader-2

PROTAC SOS1 degrader-2

PROTAC SOS1 degrader-1

BAY-293

BAY-293 相关产品

•相关化合物库:

SOS1-IN-8

SOS1-IN-11

MRTX0902

NSC-658497

NSC-658497

NSC-658497